Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000125319 | SCV000168765 | benign | not specified | 2014-02-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001079626 | SCV000562281 | benign | Intellectual disability, autosomal dominant 6; Developmental and epileptic encephalopathy, 27 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000604796 | SCV000745555 | likely benign | Intellectual disability, autosomal dominant 6 | 2017-06-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312883 | SCV000849060 | likely benign | Inborn genetic diseases | 2017-02-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000476684 | SCV001144115 | benign | not provided | 2018-11-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000476684 | SCV004134484 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | GRIN2B: BP4, BP7, BS1 |
Diagnostic Laboratory, |
RCV000604796 | SCV000733146 | likely benign | Intellectual disability, autosomal dominant 6 | no assertion criteria provided | clinical testing |